MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/rmdopen-2020-001192

Медицинская библиотека · RMD open · 2020

Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI).

Piga Matteo, Floris Alberto, Espinosa Gerard, Serpa Pinto Luísa, Kougkas Nikolaos, Lo Monaco Andrea, Lopalco Giuseppe, Orlando Ida, Pirani Vittorio, Santos Ernestina, Bertsias George, Cantarini Luca, Cauli Alberto, Cervera Ricard, Correia João, Govoni Marcello, Iannone Florenzo, Neri Piergiorgio, Martins Silva Ana, Vasconcelos Carlos, Muntoni Monica, Mathieu Alessandro, the BODI Project Group

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

To develop and validate the evidence-based and consensus-based Behçet's Syndrome Overall Damage Index (BODI).

METHODS

Starting from 120 literature-retrieved preliminary items, the BODI underwent multiple Delphi rounds with an international multidisciplinary panel consisting of rheumatologists, internists, ophthalmologists, neurologists, and patient delegates until consensus was reached on the final content. The BODI was validated in a cross-sectional multicentre cohort of 228 patients with Behçet's syndrome (BS) through the study of (a) correlation between BODI and Vasculitis Damage Index (VDI) and (b) correlation between BODI and disease activity measures (ie, Behçet's Disease Current Activity Form (BDCAF), Physician Global Assessment (PGA), Patient Global Assessment (PtGA)), c) content and face validity and (d) feasibility.

RESULTS

The final BODI consists of 4 overarching principles and 46 unweighted-items grouped into 9 organ domains. It showed good to excellent reliability, with a mean Cohen's k of 0.84 (95% CI 0.78 to 0.90) and a mean intra-class correlation coefficient of 0.88 (95% CI 0.80 to 0.95). Overall, 128 (56.1%) patients had a BODI score ≥1, with a median score of 1.0 (range 0-14). The BODI significantly correlated with the VDI (r=0.693, p<0.001), demonstrating to effectively measure damage (construct validity), but had greater sensitivity in identifying major organ damage and did not correlate with disease activity measures (ie, BDCAF: p=0.807, PGA: p=0.820, PtGA: p=0.794) discriminating damage from the major confounding factor. The instrument was deemed credible (face validity), complete (content validity) and feasible by an independent group of clinicians.

CONCLUSIONS

Pending further validation, the BODI may be used to assess organ damage in patients with BS in the context of observational and controlled trials.

Для цитирования: Piga Matteo, Floris Alberto, Espinosa Gerard, Serpa Pinto Luísa, Kougkas Nikolaos, Lo Monaco Andrea, Lopalco Giuseppe, Orlando Ida, Pirani Vittorio, Santos Ernestina, Bertsias George, Cantarini Luca, Cauli Alberto, Cervera Ricard, Correia João, Govoni Marcello, Iannone Florenzo, Neri Piergiorgio, Martins Silva Ana, Vasconcelos Carlos, Muntoni Monica, Mathieu Alessandro, the BODI Project Group. Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI).. RMD open. 2020. DOI: 10.1136/rmdopen-2020-001192.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.